Preclinical Development of Novel Therapeutics That Attenuate Virulence of, and Inhibit Resistance in, Class a Bacterial Pathogens
Contract Overview
Contract Amount: $15,071,885 ($15.1M)
Contractor: Achaogen, Inc.
Awarding Agency: Department of Defense
Start Date: 2006-10-06
End Date: 2010-10-05
Contract Duration: 1,460 days
Daily Burn Rate: $10.3K/day
Official Description: PRECLINICAL DEVELOPMENT OF NOVEL THERAPEUTICS THAT ATTENUATE VIRULENCE OF, AND INHIBIT RESISTANCE IN, CLASS A BACTERIAL PATHOGENS
Place of Performance
Location: California, 94080